229
Participants
Start Date
April 30, 2013
Primary Completion Date
August 27, 2015
Study Completion Date
August 31, 2016
Vismodegib
Vismodegib 150 mg hard gelatin capsule orally once daily
Placebo
Vismodegib placebo orally once daily
Medizinische Universität Wien; Univ.Klinik für Dermatologie, Vienna
LKH Innsbruck; Universitätsklinik für Dermatologie, Innsbruck
Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin
Long Island Skin Cancer and Dermatologic Surgery, Smithtown
Mariwalla Dermatology, West Islip
Hopital Timone Adultes; Dermatologie, Marseille
Hospital General Dr. Manuel Gea Gonzalez; Dermatology, México
Penn State Milton S. Hershey Medical Center, Hershey
Hospital General Universitario de Guadalajara; Servicio de Dermatologia, Guadalajara
Chu Site Du Bocage;Dermatologie, Dijon
UNI-Klinikum Campus Kiel Klinik f.Dermatologie Tagesklinik f.Dermatologie, Kiel
Università di Brescia; Dipartimento di Dermatologia, Brescia
The Skin Surgery Center, Winston-Salem
Dermatology and Laser Center of Charleston PA, Charleston
Hospital Costa Del Sol; Servicio de Dermatologia, Málaga
Emory University Clinic, Atlanta
Medizinische Hochschule Hannover; Klinik für Dermatologie, Allergologie und Venerologie, Hanover
Advanced Derm & Cosmetic Surg, Ormond Beach
Hopital Saint Andre CHU De Bordeaux; Dermatologie, Bordeaux
Skin and Cancer Associates and the Center for Cosmetic Enhancement, Plantation
Hopital Saint Eloi; CHU de Montpellier; Svc de Dermatologie, Montpellier
Hospital General Universitario de Valencia; Servicio de oncologia, Valencia
Arcispedale Santa Maria Nuova; Dermatologia, Reggio Emilia
Hopital Nord ; Dermatologie, Saint-Etienne
Ohio State University, Columbus
Hopital Hotel Dieu Et Hme; Clinique Dermatologique, Nantes
Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Essen
Instituto Valenciano Oncologia; Oncologia Medica, Valencia
Laser & Skin Surgery Center of Indiana, Carmel
Fachklinik Hornheide; Dermatologie, Münster
Ospedale IOT- Palagi Dermatologia 2, Florence
Klinik Johann Wolfgang von Goethe Uni; Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt
Saint Louis University School of Medicine; Department of Dermatology, St Louis
Washington University School of Medicine, St Louis
Ch Francois Mitterrand; Medecine Oncologie, Pau
Ospedale San Salvatore (ASL-01); Dip. di Dermatologia U.O.S. di Dermatologia Oncol, L’Aquila
Universitätsklinikum Tübingen Universitäts-Hautklinik, Tübingen
Hôpital Saint-Louis, Paris
CHU Amiens - Hopital Sud, Amiens
Klinikum der LMU München; Klinik und Poliklinik für Dermatologie und Allergologie, München
Hopital Dupuytren; Dermatologie, Limoges
Dermatology Research Associate, Los Angeles
Skin Surgery Med Group, Inc, San Diego
Stanford University, Palo Alto
California Pacific Medical Center Research Institute, Santa Rosa
Blokhin Cancer Research Center; General Oncology Department, Moscow
"FSBI Russian Oncology Research Center n.a. N. N. Blokhin of Ministry of Health of the Russian Fed", Moscow
City Clinical Oncology Dispensary, Saint Petersburg
Beverly Hospital;Oncology Center Pharmacy, Beverly
UBC Department of Dermatology & Skin Sciences, Vancouver
Dermetics, Burlington
Innovaderm Research Inc., Montreal
SRH Wald-Klinikum Gera; Klinik für Hautkrankheiten und Allergologie, Gera
Hospital General de México, Mexico City
VU MEDISCH CENTRUM;Afdeling Dermatologie, Amsterdam
Academ Ziekenhuis Groningen; Medical Oncology, Groningen
Maastricht University Medical Centre; Dermatologie, Maastricht
Hospital Clinic i Provincial; Servicio de Farmacia, Barcelona
Hoffmann-La Roche
INDUSTRY